These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 25566237)
1. Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus. Navari M; Fuligni F; Laginestra MA; Etebari M; Ambrosio MR; Sapienza MR; Rossi M; De Falco G; Gibellini D; Tripodo C; Pileri SA; Leoncini L; Piccaluga PP Front Microbiol; 2014; 5():728. PubMed ID: 25566237 [TBL] [Abstract][Full Text] [Related]
2. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas. Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
4. The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Ambrosio MR; Navari M; Di Lisio L; Leon EA; Onnis A; Gazaneo S; Mundo L; Ulivieri C; Gomez G; Lazzi S; Piris MA; Leoncini L; De Falco G Infect Agent Cancer; 2014; 9():12. PubMed ID: 24731550 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex. Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003 [TBL] [Abstract][Full Text] [Related]
7. The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma. Navari M; Etebari M; De Falco G; Ambrosio MR; Gibellini D; Leoncini L; Piccaluga PP Front Microbiol; 2015; 6():556. PubMed ID: 26113842 [TBL] [Abstract][Full Text] [Related]
8. Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders. Crombie JL; LaCasce AS Front Oncol; 2019; 9():109. PubMed ID: 30899698 [TBL] [Abstract][Full Text] [Related]
9. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239 [TBL] [Abstract][Full Text] [Related]
10. EBV-Encoded Latent Genes. Kanda T Adv Exp Med Biol; 2018; 1045():377-394. PubMed ID: 29896676 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153 [TBL] [Abstract][Full Text] [Related]
12. Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases. Hui KF; Yiu SPT; Tam KP; Chiang AKS Front Oncol; 2019; 9():81. PubMed ID: 30873380 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated lymphomas. Shannon-Lowe C; Rickinson AB; Bell AI Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893938 [TBL] [Abstract][Full Text] [Related]
14. Biological Difference Between Epstein-Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact. Ferla V; Rossi FG; Goldaniga MC; Baldini L Front Oncol; 2020; 10():506. PubMed ID: 32457824 [TBL] [Abstract][Full Text] [Related]